It has already been shown that serine hydroxymethyltransferase 2 (SHMT2) was highly expressed in glioma cells surrounding the necrosis zone and hypoxia drives the expression of the key enzymes of serine metabolism in glioma [9]. This evidence concerns the gene SHMT2 and central nervous system cancer.